SCHEMBL29469741

SCHEMBL29469741

COc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.79
MAPT P10636 4/20 0.79
MEN1 O00255 4/20 0.79
KMT2A Q03164 4/20 0.79
TDP1 Q9NUW8 3/20 0.79
HTT P42858 2/20 0.79
HPGD P15428 2/20 0.79
RECQL P46063 2/20 0.79
BLM P54132 2/20 0.79
PRMT1 Q99873 2/20 0.79
ACE2 Q9BYF1 2/20 0.79
CYP2C19 P33261 1/20 0.79
SMAD3 P84022 1/20 0.79
LMNA P02545 3/20 0.67
ALDH1A1 P00352 3/20 0.67
USP2 O75604 2/20 0.67
CYP3A4 P08684 2/20 0.65
GPR55 Q9Y2T6 2/20 0.60
ALOX12 P18054 2/20 0.60
POLB P06746 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622095 1.00 FTO (0.79) FTOMAPTMEN1KMT2ATDP1
SCHEMBL29386324 0.93 CYP3A4 (0.74) FTOMAPTMEN1KMT2ATDP1
SCHEMBL1930643 0.93 CYP3A4 (0.74) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL5694330 0.91 FTO (0.89) FTOMAPTMEN1KMT2ATDP1
SCHEMBL28605114 0.90 FTO (0.66) FTOMAPTMEN1KMT2ATDP1
SCHEMBL4663321 0.90 FTO (0.82) FTOMAPTMEN1KMT2ATDP1
SCHEMBL7740798 0.89 FTO (0.81) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL8648355 0.89 FTO (0.94) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL16533 0.89 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL29388667 0.89 FTO (1.00) FTOMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12345641-B2 Fluorescence quenching immunoassay IDEZZ Laboratories, Inc. (US) 2025-07-01 US disclosed
US-20250123564-A1 RESIST COMPOSITION AND METHOD OF FORMING PATTERN BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-04-17 US disclosed
EP-4379062-A1 BIOSYSTEM FOR PESTICIDE DETECTION Fundación AZTI - AZTI Fundazioa (ES) 2024-06-05 EP disclosed
US-20240175069-A1 BIOSYSTEM FOR PESTICIDE DETECTION Fundación AZTI – AZTI Fundazioa (ES) 2024-05-30 US disclosed
US-20240060949-A1 BIOSYSTEMS TO DETECT CHEMICAL CONTAMINANTS FUNDACION AZTI/AZTI FUNDAZIOA (ES) 2024-02-22 US disclosed
EP-4271830-A1 BIOSYSTEMS TO DETECT CHEMICAL CONTAMINANTS Fundacion Azti/Azti Fundazioa (ES) 2023-11-08 EP disclosed
EP-4136141-A2 FLUORESCENCE QUENCHING IMMUNOSSAY IDEXX Laboratories, Inc. (US) 2023-02-22 EP disclosed
CN-115215837-A Fused ring p-benzoquinone dimer derivative containing triazole ring and preparation method and application thereof 山东大学 2022-10-21 CN disclosed
WO-2022144095-A1 BIOSYSTEMS TO DETECT CHEMICAL CONTAMINANTS FUNDACION AZTI/AZTI FUNDAZIOA (ES) 2022-07-07 WO disclosed
US-20220082501-A1 FLUORESCENCE QUENCHING IMMUNOASSAY IDEXX LABORATORIES, INC. 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220082501-A1 FLUORESCENCE QUENCHING IMMUNOASSAY NQO2, FCGRT, MPO FTO 934/4885MAPT 2809/4885MEN1 3279/4885
US-12345641-B2 Fluorescence quenching immunoassay NQO2, FCGRT, MPO FTO 934/4885MAPT 2809/4885MEN1 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.